SPY421.97-0.14 -0.03%
DIA338.65-2.11 -0.62%
IXIC14,161.35+121.67 0.87%

--Wedbush Upgrades Stoke Therapeutics to Outperform From Neutral, Citing Stock Pullback; Price Target to $47 From $53

05/10/2021 05:03

08:58 AM EDT, 05/10/2021 (MT Newswires) -- (MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www.mtnewswires.com/contact-us)

Price: 32.75, Change: +0.29, Percent Change: +0.89